Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521854 · ClinicalTrials.gov registry record · NA
Contingency Management for Drug Use: Does Age Matter?
A NA study of Opioid Use Disorder and Cocaine Use Disorder, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 2
- Study locations
NCT05521854: Active NA study of Opioid Use Disorder and Cocaine Use Disorder, sponsored by Wake Forest University Health Sciences.
NCT05521854 is a NA study of Opioid Use Disorder and Cocaine Use Disorder that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 175 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521854, a NA study of Opioid Use Disorder and Cocaine Use Disorder, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 2
- Study locations
Study Summary
The OVERALL AIM is to assess whether app-based incentives are effective for older adults and to quantify the associations between age and both the efficacy and take-up of app-based incentives. This will allow us to determine if older adults with substance use disorders (SUDs) are willing to engage with app-based incentives and whether they perform similarly to their younger counterparts. Because the study will leverage data from an existing study on app-based incentives, a small add-on study is sufficient to address these three aims. This aim will be achieved while simultaneously gathering data that will shed light on the two aims of the first phase of the study: whether app-based incentives are effective overall, and how to optimize the size of incentives over time to maximize their effectiveness.
Primary Outcome
Percent of three (3) scheduled video-verified saliva test results classified as drug-negative
Conditions Studied
Interventions
- BEHAVIORAL DynamiCare app (app-based contingency management)
- BEHAVIORAL Sham control
Study Locations (2)
Illinois
- Advocate Health Care - Chicago
Wisconsin
- Aurora Behavioral Health Services - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05521854 still lists
NCT05521854 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which DynamiCare app (app-based contingency management) is the first listed.
NCT05521854 reports a single indexed study location in Illinois, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05521854 about?
NCT05521854 is a clinical study titled "Contingency Management for Drug Use: Does Age Matter?". The OVERALL AIM is to assess whether app-based incentives are effective for older adults and to quantify the associations between age and both the efficacy and take-up of app-based incentives. This will allow us to determine if older adults with substance use disorders (SUDs) are willing to engage w...
What is the current status of trial NCT05521854?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2023-05-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05521854 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Cocaine Use Disorder, Methamphetamine Abuse.
What interventions are being tested in trial NCT05521854?
The interventions under investigation include: DynamiCare app (app-based contingency management) (BEHAVIORAL), Sham control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05521854?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521854 being conducted?
This trial has 2 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05521854's enrollment target sits among peer trials
175 104th of 257 higher than 154 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI